13 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
6 more records may belong here and await a decision; they are not counted.
The next term ends in Dec 2030. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Dec 2030
Next term end
6
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Dec 2030 · High confidence
Also notable
Ends Mar 2036 · High confidence
Also notable
Ends Mar 2036 · High confidence
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
US 7,335,799
The most cited patent in this portfolio, cited by 55 later US patents, top 25% of utility patents granted in 2008 in our data. Protection runs to 2030.
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing Cardiovascular Disease
US 11,116,739
Cited by 6 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2036.
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
US 10,912,751
Cited by 6 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2036.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Mar 5 to 19, 2027 · next Mar 5
- 1 fee due Sep 12, 2027The maintenance fee for Methods of Making Bempedoic Acid and Compositions of the Same (US 11,926,584) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
What they patent
The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,335,799 | Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses In force · High confidence | In force | High confidence | |
| US 10,912,751 | Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease In force · High confidence | In force | High confidence | |
| US 11,744,816 | Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease In force · High confidence | In force | High confidence | |
| US 11,116,739 | Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing Cardiovascular Disease In force · High confidence | In force | High confidence | |
| US 11,407,705 | Methods of Making Bempedoic Acid and Compositions of the Same In force · High confidence | In force | High confidence | |
| US 11,613,511 | Methods of Making Bempedoic Acid and Compositions of the Same In force · Medium confidence | In force | Medium confidence | |
| US 11,760,714 | Methods of Making Bempedoic Acid and Compositions of the Same In force · High confidence | In force | High confidence | |
| US 11,926,584 | Methods of Making Bempedoic Acid and Compositions of the Same In force · Medium confidence | In force | Medium confidence | |
| US 11,987,548 | Methods of Making Bempedoic Acid and Compositions of the Same In force · Medium confidence | In force | Medium confidence | |
| US 12,398,087 | Methods of Making Bempedoic Acid and Compositions of the Same In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 13: 30 patents ended · 8 applications pending · 26 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.